AstraZeneca’s win in lung cancer; Sandoz inks a China deal
A combination of AstraZeneca's Tagrisso and Hutchmed's Orpathys extended survival for some lung cancer patients. Elsewhere, MapLight started seeking a partner for its autism drug.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.